ZA984650B - Intratumoral administration of triphenylethylenes for the treatment of cancer - Google Patents

Intratumoral administration of triphenylethylenes for the treatment of cancer

Info

Publication number
ZA984650B
ZA984650B ZA984650A ZA984650A ZA984650B ZA 984650 B ZA984650 B ZA 984650B ZA 984650 A ZA984650 A ZA 984650A ZA 984650 A ZA984650 A ZA 984650A ZA 984650 B ZA984650 B ZA 984650B
Authority
ZA
South Africa
Prior art keywords
triphenylethylenes
cancer
treatment
intratumoral administration
intratumoral
Prior art date
Application number
ZA984650A
Inventor
Michael Degregorio
Lauri Kangas
Kauko Kurkela
Tapani Vaha-Vahe
Kaija Af Ursin
Juha Kiesvaara
Original Assignee
Orion Corp
Michael Degregorio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp, Michael Degregorio filed Critical Orion Corp
Publication of ZA984650B publication Critical patent/ZA984650B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
ZA984650A 1997-06-19 1998-05-29 Intratumoral administration of triphenylethylenes for the treatment of cancer ZA984650B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87925297A 1997-06-19 1997-06-19

Publications (1)

Publication Number Publication Date
ZA984650B true ZA984650B (en) 1998-12-08

Family

ID=25373740

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984650A ZA984650B (en) 1997-06-19 1998-05-29 Intratumoral administration of triphenylethylenes for the treatment of cancer

Country Status (3)

Country Link
AU (1) AU7920198A (en)
WO (1) WO1998058634A2 (en)
ZA (1) ZA984650B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413534B1 (en) 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
DE1003496T1 (en) * 1998-05-07 2000-11-02 Univ Tennessee Res Corp Method of preventing prostate cancer
US6413533B1 (en) 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
WO2016106146A1 (en) 2014-12-23 2016-06-30 The Regents Of The University Of California Methods for immunomodulation of cancer and infectious disease therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
WO1998058634A2 (en) 1998-12-30
AU7920198A (en) 1999-01-04
WO1998058634A3 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
PL354540A1 (en) Drugs for the treatment of malignant tumours
EG24678A (en) Combination therapy
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
ZA983176B (en) Therapeutic compounds
HK1024622A1 (en) Il 12 for the gene therapy of tumours
GB2323531B (en) Therapeutic formulations
AU2508597A (en) Drug for the treatment of tumours
IL127306A0 (en) Combination therapy
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
GB9700939D0 (en) Therapy
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
ZA984650B (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
GB9703633D0 (en) Cancer therapy
IL135994A0 (en) Combination therapy for the treatment of aids
IL149281A0 (en) Treatment of cancer
GB9716345D0 (en) Therapeutic compounds
GB9819999D0 (en) Treatment of cancer
GB9716344D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB0020261D0 (en) Therapeutic treatment
AU1014997A (en) A drug for the treatment of cancer
IL127826A0 (en) Restenosis drug therapy
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders